Geographic region, stroke risk and renal function strongly affect treatment choice for stroke prevention in patients with non-valvular AF: results from the GLORIA-AF registry program
机构：[1]c/o Theresa Oberst, Nürnberg, Germany[2]Boehringer Ingelheim International GmbH, Ingelheim, Germany[3]Birmingham City Hospital, Birmingham, United Kingdom[4]Leiden University Medical Center, Leiden, Netherlands[5]Mount Sinai School of Medicine, New York, United States of America[6]University Hospital of Essen (Ruhr), Essen, Germany[7]Clínica y Maternidad Suizo Argentina, Buenos Aires, Argentina[8]Beijing Anzhen Hospital, Beijing, China People’s Republic of首都医科大学附属安贞医院[9]Boehringer Ingelheim Corporation, Burlington, Ontario, Canada[10]Boehringer Ingelheim Corporation, Ridgefield, Connecticut, United States of America[11]RTI Health Solutions, Durham, North Carolina, United States of America. On behalf of GLORIA-AF investigators
L.Beier,L.R.Franca,G.Y.H.Lip,et al.Geographic region, stroke risk and renal function strongly affect treatment choice for stroke prevention in patients with non-valvular AF: results from the GLORIA-AF registry program[J].EUROPEAN HEART JOURNAL.2018,39:1074-1074.
APA：
L.Beier,L.R.Franca,G.Y.H.Lip,M.V.Huisman,K.Zint...&K.J.Rothman.(2018).Geographic region, stroke risk and renal function strongly affect treatment choice for stroke prevention in patients with non-valvular AF: results from the GLORIA-AF registry program.EUROPEAN HEART JOURNAL,39,
MLA：
L.Beier,et al."Geographic region, stroke risk and renal function strongly affect treatment choice for stroke prevention in patients with non-valvular AF: results from the GLORIA-AF registry program".EUROPEAN HEART JOURNAL 39.(2018):1074-1074
医学